When a crowd is your investor : crowdfunding and IPO in Pharma Industry

After 3 years, Recipharm's Drug Development meetup is coming back to life!
The scientific challenges in drug development are only one part of the roadmap. The other main challenge is the financial support needed to overcome the scientific challenges. It is even more thrilling when your investors can be everyone in the universe. In this meetup, our speakers will share their vision on the IPO and crowdfunding in the sensitive pharma industry.

Our speakers:
Dr. Lior Shaltiel, CEO NurExone Biologic
“NurExone: Out of the box thinking to finance early stage biopharma companies”

Alon Ben-Noon, CEO NeuroSene
“NeuroSense - evolving with Crowdfunding to an IPO”

Sarel Chen-Tov, co-founder Cannabotech, CEO of Biopharmax
“Cannabotech: IPO based crowdfunding”